logo

TMCI

Treace Medical·NASDAQ
--
--(--)
--
--(--)

TMCI fundamentals

Treace Medical (TMCI) expects to report earnings on Feb 26, 2026, with estimated revenue of 61.85M (YoY -9.98%), and EPS at -0.1519 (YoY -1419.00%).
Revenue estimate / YoY
61.85M
-9.98%
EPS estimate / YoY
-0.1519
-1419.00%
Report date
Feb 26, 2026
EPS
Revenue

Revenue & Expenses

TMCI has released its 2025 Q3 earnings report, with revenue of 50.21M, reflecting a YoY change of 11.37%, and net profit of -16.29M, showing a YoY change of -6.04%. The Sankey diagram below clearly presents TMCI's revenue sources and cost distribution.

Key Indicators

Treace Medical (TMCI) key financial stats and ratios, covering profitability, financial health, and leverage.
Treace Medical (TMCI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Treace Medical (TMCI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Treace Medical (TMCI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Treace Medical (TMCI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Treace Medical (TMCI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield